Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
NCT07763522
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced ParesisHelsinki University Central HospitalEnrolling By InvitationNot Applicable
NCT07763522Enrolling By Invitation
Not Applicable
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Asses...Helsinki University Centr...
NCT07762300
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary IncontinenceBenha UniversityRecruitingNot Applicable
NCT07762300Recruiting
Not Applicable
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary...Benha University
NCT07762820
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder TumorsLudwig-Maximilians - University of MunichNot Yet RecruitingNot Applicable
NCT07762820Not Yet Recruiting
Not Applicable
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retr...Ludwig-Maximilians - Univ...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan UniversityRecruitingPhase 2
NCT07762924Recruiting
Phase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Fol...Fudan University
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07764016
DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial DiseaseCardionovum GmbHNot Yet RecruitingNot Applicable
NCT07764016Not Yet Recruiting
Not Applicable
DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scor...Cardionovum GmbH
NCT07762573
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective StudyNanfang Hospital, Southern Medical UniversityRecruiting
NCT07762573Recruiting
—
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment i...Nanfang Hospital, Souther...
NCT07763106
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of Patients With Pressure Ulcers Receiving Home-Based and Institutional CareSalus Care Center, Rybnik, PolandNot Yet RecruitingNot Applicable
NCT07763106Not Yet Recruiting
Not Applicable
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of P...Salus Care Center, Rybnik...
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07763054
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsHaikou Affiliated Hospital of Central South University Xiangya School of MedicineRecruiting
NCT07763054Recruiting
—
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutro...Haikou Affiliated Hospita...
NCT07761988
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society, Inc.Not Yet RecruitingNot Applicable
NCT07761988Not Yet Recruiting
Not Applicable
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society,...
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763730
Effects of Robotic Pet and Video-Based Distraction on Pain, Fear, and Anxiety in Children During VenipunctureAkdeniz UniversityCompletedNot Applicable
NCT07763730Completed
Not Applicable
Effects of Robotic Pet and Video-Based Distraction on Pain, Fear, and Anxiety in...Akdeniz University
NCT07762469
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin XuNot Yet Recruiting
NCT07762469Not Yet Recruiting
—
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin Xu
NCT07762131
AI-Based Precision Transfusion Prediction Model in Critically Ill PatientsSecond Affiliated Hospital, Zhejiang University, School of MedicineNot Yet Recruiting
NCT07762131Not Yet Recruiting
—
AI-Based Precision Transfusion Prediction Model in Critically Ill PatientsSecond Affiliated Hospita...
NCT07763080
Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After MastectomyCairo UniversityNot Yet RecruitingNot Applicable
NCT07763080Not Yet Recruiting
Not Applicable
Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase...Cairo University
Result Breakdown
Not yet recruiting12 (60%)
Recruiting6 (30%)
Enrolling by invitation1 (5%)
Completed1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 22 (10%)
Phase 31 (5%)
Phase 11 (5%)
Phase 41 (5%)